लोड हो रहा है...
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease
AIMS: Both rituximab and plasmapheresis can be associated in the treatment of immune-mediated kidney diseases. The real impact of plasmapheresis on rituximab pharmacokinetics is unknown. The aim of this study was to compare rituximab pharmacokinetics between patients requiring plasmapheresis and oth...
में बचाया:
| मुख्य लेखकों: | , , , , , , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Blackwell Science Inc
2013
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3853532/ https://ncbi.nlm.nih.gov/pubmed/23432476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12098 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|